Bismuth Chemistry Creates More Stable Cell-Penetrating Peptides
Bismuth-cyclized cell-penetrating peptides showed improved cellular entry and metabolic stability compared to linear peptides, avoiding the epimerization problems of previous cyclization methods.
Quick Facts
What This Study Found
Bismuth-cyclized cell-penetrating peptides showed improved cellular entry efficiency and metabolic stability compared to linear CPPs, without the epimerization issues of previous cyclization methods.
Key Numbers
Not specified — this is a proof-of-concept study demonstrating the bismuth cyclization method.
How They Did This
Laboratory development and testing of a novel peptide cyclization method using bismuth coordination chemistry.
Why This Research Matters
Getting drugs and research tools inside cells is a major challenge in medicine. Better cell-penetrating peptides could improve drug delivery for many conditions, from cancer to genetic diseases.
The Bigger Picture
Cell-penetrating peptides are a key technology for drug delivery, but linear peptides break down quickly. Better cyclization methods that improve stability without technical drawbacks advance the entire drug delivery field.
What This Study Doesn't Tell Us
This is an early-stage laboratory study. The bismuth-cyclized peptides need to be tested in living organisms to confirm safety and effectiveness.
Questions This Raises
- ?Is bismuth biocompatible for in vivo use?
- ?Can this method be applied to therapeutic peptide cargoes?
Trust & Context
- Key Stat:
- No epimerization Bismuth cyclization avoids the amino acid scrambling (epimerization) that plagued previous peptide cyclization methods
- Evidence Grade:
- Rated preliminary: proof-of-concept chemistry study demonstrating the method. Biological applications need further validation.
- Study Age:
- Published in 2024. Novel chemistry approach with potential broad applications in peptide drug delivery.
- Original Title:
- Bismuth-Cyclized Cell-Penetrating Peptides.
- Published In:
- Molecular pharmaceutics, 21(10), 5255-5260 (2024)
- Authors:
- Ritchey, Jeremy L, Filippi, Lindsi, Ballard, Davis, Pei, Dehua
- Database ID:
- RPEP-09150
Evidence Hierarchy
Frequently Asked Questions
Why cyclize cell-penetrating peptides?
Cyclization makes peptides more rigid, improving their ability to enter cells and resist degradation by enzymes in the body.
What is bismuth cyclization?
A new chemical method using bismuth atoms to create ring-shaped peptides, avoiding technical problems that limited previous cyclization approaches.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09150APA
Ritchey, Jeremy L; Filippi, Lindsi; Ballard, Davis; Pei, Dehua. (2024). Bismuth-Cyclized Cell-Penetrating Peptides.. Molecular pharmaceutics, 21(10), 5255-5260. https://doi.org/10.1021/acs.molpharmaceut.4c00688
MLA
Ritchey, Jeremy L, et al. "Bismuth-Cyclized Cell-Penetrating Peptides.." Molecular pharmaceutics, 2024. https://doi.org/10.1021/acs.molpharmaceut.4c00688
RethinkPeptides
RethinkPeptides Research Database. "Bismuth-Cyclized Cell-Penetrating Peptides." RPEP-09150. Retrieved from https://rethinkpeptides.com/research/ritchey-2024-bismuthcyclized-cellpenetrating-peptides
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.